...
首页> 外文期刊>Experimental Neurology >Localised non-viral delivery of nucleic acids for nerve regeneration in injured nervous systems
【24h】

Localised non-viral delivery of nucleic acids for nerve regeneration in injured nervous systems

机译:损伤神经系统中神经再生的核酸局部非病毒递送

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Axons damaged by traumatic injuries are often unable to spontaneously regenerate in the adult central nervous system (CNS). Although the peripheral nervous system (PNS) has some regenerative capacity, its ability to regrow remains limited across large lesion gaps due to scar tissue formation. Nucleic acid therapy holds the potential of improving regeneration by enhancing the intrinsic growth ability of neurons and overcoming the inhibitory environment that prevents neurite outgrowth. Nucleic acids modulate gene expression by over-expression of neuronal growth factor or silencing growth-inhibitory molecules. Although in vitro outcomes appear promising, the lack of efficient non-viral nucleic acid delivery methods to the nervous system has limited the application of nucleic acid therapeutics to patients. Here, we review the recent development of efficient non viral nucleic acid delivery platforms, as applied to the nervous system, including the transfection vectors and carriers used, as well as matrices and scaffolds that are currently used. Additionally, we will discuss possible improvements for localised nucleic acid delivery.
机译:创伤损伤损坏的轴突往往无法在成人中枢神经系统(CNS)中自发地再生。虽然外周神经系统(PNS)具有一些再生能力,但由于瘢痕组织形成,其再生的再生能力仍然受到较大的病变差距。核酸疗法通过提高神经元的内在生长能力并克服预防神经突的抑制性环境来提高再生能力。核酸通过过度表达神经元生长因子或沉默生长抑制分子调节基因表达。虽然体外结果看起来很有希望,但神经系统缺乏有效的非病毒核酸输送方法限制了核酸治疗患者的应用。在这里,我们审查最近的高效非病毒核酸输送平台的发展,如应用于神经系统,包括使用的转染载体和载体,以及目前使用的基质和支架。此外,我们将讨论可能的改进局部核酸输送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号